Relationship in healthy subjects between CYP2E1 genetic polymorphisms and the 6-hydroxylation of chlorzoxazone: a putative measure of CYP2E1 activity.
Kim
R B
RB
Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232-6600.
O'Shea
D
D
Wilkinson
G R
GR
D000293:Adolescent; D000328:Adult; D001483:Base Sequence; D001711:Biotransformation; D002273:Carcinogens / Q000378:metabolism; D002753:Chlorzoxazone / Q000378:metabolism*; D019392:Cytochrome P-450 CYP2E1; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics* / Q000378:metabolism*; D017931:DNA Primers / Q000235:genetics; D005838:Genotype; D006801:Humans; D006900:Hydroxylation; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D010089:Oxidoreductases, N-Demethylating / Q000235:genetics* / Q000378:metabolism*; D011110:Polymorphism, Genetic; D012150:Polymorphism, Restriction Fragment Length
D002273:Carcinogens; D017931:DNA Primers; D003577:Cytochrome P-450 Enzyme System; D019392:Cytochrome P-450 CYP2E1; D010089:Oxidoreductases, N-Demethylating; D002753:Chlorzoxazone